White House expects COVID vaccine orders for children under 5 to pick up
Reuters
Published Jun 09, 2022 05:07AM ET
Updated Jun 09, 2022 12:41PM ET
By Jarrett Renshaw and Ahmed Aboulenein
(Reuters) -Pre-orders of vaccines for children under age five have been slow, but Biden administration senior officials say they are not alarmed and expect the pace to pick up after federal approvals later this month.
The administration expects vaccinations of young children to start as early as June 21 if the U.S. Food and Drug Administration and the Centers for Disease Control and Prevention approve the vaccines next week, White House COVID-19 response coordinator Ashish Jha said on Thursday.
"We think that vaccinations would really start in earnest on Tuesday, June 21, and importantly, the vaccination program is going to ramp up in the days and weeks that follow," he said.
The vaccines will be distributed to pediatricians, children's hospitals, local pharmacies and local health clinics, Jha told reporters in a briefing.
The administration has allowed states and others to pre-order from an initial batch of 5 million Moderna (NASDAQ:MRNA) and Pfizer (NYSE:PFE) vaccines, 2.5 million each, as a way to expedite getting needles in arms.
Thus far, 58% of the available 2.5 million Pfizer vaccines have been ordered and just 34% of the Moderna vaccines.
No COVID-19 shot has yet been approved for children in the five and under age group in most parts of the world. It remains unclear how many parents will get their young ones vaccinated as demand has been low in kids aged five to 11.
The administration has learned from previous campaigns that the people weighing whether to take a vaccine or get their child vaccinated will be influenced by those they trust, such as doctors and community leaders.
"We will be working closely with community partners, as we have done in the past, to make sure that community members are hearing from local leaders and organizations that they know and trust," U.S. Surgeon General Vivek Murthy said at the briefing.
Get The News You Want
Written By: Reuters
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.